The Marathon Endurance Study
This double-blind, placebo-controlled study examines the role of probiotic administration in the prevention of C. difficile-associated diarrhoea (CDAD) in elderly patients receiving antibiotic therapy.
Results showed that Lab4 probiotics reduced the incidence of Clostridium difficile diarrhoea in these patients.
46% of patients supplemented with Lab4 probiotics were positive for Clostridium difficile toxin compared to 78% of patients in the placebo group
Gut symptoms during 28-day supplementation period
Gut Symptoms during the marathon race
Lab4 probiotics supplementation protects endurance runners from gut disturbances during a marathon race and may help to maintain running pace during the latter stages of racing.